TrialBMC psychiatry2023

Agomelatine augmentation of sertraline in the treatment of moderate to severe obsessive-compulsive disorder: a randomized double-blinded placebo-controlled clinical trial.

Marjan Shokrani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.